ERBB2 and breast cancer: As expected pathological sub-types were different between age groups, those who presented with BC at younger ages had higher stage, higher histopathological grade, higher grade of nucleus, higher lymphovascular invasion, higher rate of BCS, and higher rates of HER2 expression, and majority of these individuals used tamoxifen as their hormone therapy regimen.